Literature DB >> 22945743

Effects of chronic baclofen use on active movement in an individual with a spinal cord injury.

C Angeli1, J Ochsner, S Harkema.   

Abstract

STUDY
DESIGN: Case report.
OBJECTIVES: To describe a case of chronic use of oral baclofen in a patient with spinal cord injury limiting lower extremity movements.
SETTING: Frazier Rehab Institute, Louisville, Kentucky and University of Louisville. REPORT: A 24-year-old male with a C5 AIS-B spinal cord injury received a neurophysiological examination pre and post cessation of the use of oral baclofen. The initial results revealed no motor activity below the level of the lesion during reinforcement maneuvers or active movements. Following discontinuance of baclofen, motor activity was detected in upper and lower extremity muscles during some tasks. Locomotor patterns during stepping on a treadmill with body weight support did not reveal excessive overactivity of the lower extremity muscles. The patient was also able to perform squats independently at 35-40% body weight support when standing on a treadmill.
CONCLUSION: Baclofen is typically prescribed for the management of spasticity in individuals with spinal cord injury. The interaction of reduced spasticity on functional tasks is not well understood, raising an important limitation of neurological exams and classifications done under heavy dosages of medication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22945743     DOI: 10.1038/sc.2012.93

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  4 in total

1.  Rehabilitation Decreases Spasticity by Restoring Chloride Homeostasis through the Brain-Derived Neurotrophic Factor-KCC2 Pathway after Spinal Cord Injury.

Authors:  Henrike Beverungen; Samantha Choyke Klaszky; Michael Klaszky; Marie-Pascale Côté
Journal:  J Neurotrauma       Date:  2019-11-13       Impact factor: 5.269

2.  Antispasmodic medications may be associated with reduced recovery during inpatient rehabilitation after traumatic spinal cord injury.

Authors:  Eric R Theriault; Vincent Huang; Gale Whiteneck; Marcel P Dijkers; Noam Y Harel
Journal:  J Spinal Cord Med       Date:  2016-11-14       Impact factor: 1.985

3.  Enhancing KCC2 activity decreases hyperreflexia and spasticity after chronic spinal cord injury.

Authors:  Jadwiga N Bilchak; Kyle Yeakle; Guillaume Caron; Dillon Malloy; Marie-Pascale Côté
Journal:  Exp Neurol       Date:  2021-01-13       Impact factor: 5.330

4.  Insulin-like growth factor-1 enhances neuroprotective effects of neural stem cell exosomes after spinal cord injury via an miR-219a-2-3p/YY1 mechanism.

Authors:  Ke Ma; Huiyou Xu; Jian Zhang; Fei Zhao; Haiqian Liang; Hongtao Sun; Ping Li; Sai Zhang; Renjie Wang; Xuyi Chen
Journal:  Aging (Albany NY)       Date:  2019-12-17       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.